Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment od Smith, EA, Belote, RL, Cruz, NM, Moustafa, TE, Becker, CA, Jiang, A, Alizada, S, Prokofyeva, A, Chan, TY, Seasor, TA, Balatico, M, Cortes-Sanchez, E, Lum, DH, Hyngstrom, JR, Zeng, H, Deacon, DC, Grossmann, AH, White, RM, Zangle, TA, Judson-Torres, RL